Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 8/20 | 0.50 |
| ▸ | NPC1 | O15118 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | MMP8 | P22894 | 1/20 | 0.42 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9547549 | 0.83 | EPHX1 (0.54) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL22251702 | 0.79 | TSHR (0.38) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL27808066 | 0.79 | TSHR (0.38) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL27808081 | 0.79 | TSHR (0.38) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL22251761 | 0.77 | TSHR (0.35) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL9538240 | 0.76 | EPHX1 (0.50) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL5705094 | 0.76 | EPHX1 (0.50) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL679618 | 0.76 | CCR5 (0.52) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL12506208 | 0.74 | ADRA2A (0.56) | EPHX1NPC1SMN1; SMN2RAB9AMAPT | |
| SCHEMBL6684532 | 0.74 | EPHX1 (0.48) | EPHX1NPC1SMN1; SMN2RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234986-A1 | INHIBITORS OF CORONAVIRUS PROTEASE | SUNSHINE BIOPHARMA INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230234986-A1 | INHIBITORS OF CORONAVIRUS PROTEASE | SUNSHINE BIOPHARMA INC. | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234986-A1 | INHIBITORS OF CORONAVIRUS PROTEASE | ACE2, ACE, TMPRSS2 | EPHX1 2253/4885NPC1 813/4885SMN1; SMN2 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.